Richard Pazdur

72PUBLICATIONS
312CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMedical biotechnology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (72)

|Mar 06, 2026
FDA Approval Summary: Pembrolizumab for the Treatment of HER2-Positive Gastric Cancer.

Sandra J Casak, Yiming Zhang, Chi Song

|Mar 04, 2026
Oncology Drug Development: Challenges of Increasingly Available Therapies.

Sundeep Agrawal, Richard Pazdur

|Feb 12, 2026
FDA Approval Summary: Durvalumab for the Treatment of Adult Patients with Muscle-Invasive Bladder Cancer.

Nooshin Mirkheshti, Daniel Edem Kpormegbey, Chana Weinstock

|Jan 26, 2026
FDA Approval Summary: Tarlatamab for the Treatment of Extensive-Stage Small Cell Lung Cancer.

Yufan Liu, Jeannette Nashed, Amy K Barone

|Jan 09, 2026
Project 5 in 5: Paving the Way for Increasing Pragmatism in Clinical Oncology Trials.

Steven Clark Cunningham, Kelly Norsworthy, Jennifer J Gao

|Oct 31, 2025
Reply to: Decoding the End Points of Poly (ADP-ribose) Polymerase Inhibitor Trials in Ovarian Cancer.

Mirat Shah, Mallorie H Fiero, Joyce Cheng

Pageof 12

Frequent Collaborators

28 joint publications

Laleh Amiri-Kordestani

28 joint publications

Shenghui Tang

24 joint publications

Paul Kluetz

19 joint publications

William Pierce